
Bausch Health Companies Inc.: updates and filings
Price
$8.56
November 19, 2026Market cap $3.2B
What Ploutos Investor adds for Bausch Health Companies
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 24% since Oct 28, 2026, when the 10-Q these figures come from was filed ($6.92 then, $8.56 on Nov 19, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 28, 2026next Jan 29, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
April 2026
February 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 28, 2026Results of operationsForm8-K
- Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Results of operationsForm8-K
- Jul 1, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jun 1, 2026Conflict minerals reportFormSD
- May 19, 2026Shareholder voteForm8-K
- Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 29, 2026Results of operationsForm8-K
- Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 8, 2026Additional annual meeting materialFormDEFA14A
- Apr 8, 2026Annual meeting proxy statementFormDEF 14A
- Mar 2, 2026Officer or director changeForm8-K
- Feb 19, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 18, 2026Results of operationsForm8-K
- Jan 23, 2026Regulation FD disclosureForm8-K
- Jan 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Jan 2, 2026Material agreement entered, new material financial obligation, other material eventsForm8-K
- Dec 29, 2025Material agreement entered, new material financial obligationForm8-K
- Dec 23, 2025Other material eventsForm8-K
- Dec 12, 2025Other material eventsForm8-K
- Dec 9, 2025Other material eventsForm8-K
- Nov 24, 2025Other material eventsForm8-K
- Nov 14, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 30, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 28, 2026 | 8-K | Results of operations | Document |
| Jul 30, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Results of operations | Document |
| Jul 1, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jun 1, 2026 | SD | Conflict minerals report | Document |
| May 19, 2026 | 8-K | Shareholder vote | Document |
| Apr 30, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 29, 2026 | 8-K | Results of operations | Document |
| Apr 8, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 8, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 8, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 2, 2026 | 8-K | Officer or director change | Document |
| Feb 19, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 18, 2026 | 8-K | Results of operations | Document |
| Jan 23, 2026 | 8-K | Regulation FD disclosure | Document |
| Jan 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jan 2, 2026 | 8-K | Material agreement entered, new material financial obligation, other material events | Document |
| Dec 29, 2025 | 8-K | Material agreement entered, new material financial obligation | Document |
| Dec 23, 2025 | 8-K | Other material events | Document |
| Dec 12, 2025 | 8-K | Other material events | Document |
| Dec 9, 2025 | 8-K | Other material events | Document |
| Nov 24, 2025 | 8-K | Other material events | Document |
| Nov 14, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 30, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since May 22, 1996: every report, 8-K, meeting and letter. Of its other filings (1,191 in all), the newest.
The full analysis
What do Bausch Health Companies's filings show?
The filings are where every one of Bausch Health Companies's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.